|
Dr. Nemeroff joined NovaDel’s Board in September 2003. He has been the Reunette W. Harris Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia since 1991. Dr. Nemeroff serves on the scientific advisory board of numerous publicly-traded pharmaceutical companies including Cypress Bioscience Inc., Astra-Zeneca Pharmaceuticals, Forest Laboratories, Janssen, Organon, GlaxoSmithKline Beecham and Wyeth-Ayerst and is clinical advisory to Acadia Pharmaceutical. In 2002, Dr. Nemeroff was elected to the Institute of Medicine.
Dr. Nemeroff received his B.S. from the City College of New York, his M.S. from Northeastern University, his Ph.D. and Post doctorate from the University of North Carolina and his M.D. from the University of North Carolina.
| 